Pay in 4 interest-free payments of $6.31 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Glucagon-Like Peptide-1 receptor agonists as potential Myelination-Inducible and Anti-Demyelinating remedies
10.3389/fimmu.2019.01050 Summary Keywords T2DM, incretin effect, DPP-4 enzyme, DPP-4 inhibitors, (GLP)-1, insulin Citation Saini K, Sharma S and Khan Y (2023) DPP-4 inhibitors for treating T2DM - hype or hope
Unlike GLP-1 analogs that primarily modulate insulin secretion and appetite through the glucagon-like peptide-1 pathway, cagrilintide offers a complementary pathwaywhich is why its frequently studied in conjunction with semaglutide and tirzepatide
J Vet Sci 15:2733
US$ 28.70
US$ 24.90
US$ 22.21
